At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ZYME ZYMEWORKS INC (US)
Trading 01-22 11:55:14 EST
23.94
-0.01
-0.04%
High24.31Low23.86Vol153.16K
Open23.95D1 Closing23.95Amplitude1.88%
Mkt Cap1.79BTradable Cap916.89MTotal Shares74.84M
T/O3.69MT/O Rate0.40%Tradable Shares38.30M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Zymeworks Inc. unveils strategy focused on growing royalty portfolio and advancing novel medicines for difficult-to-treat diseases
Reuters  ·  01-21 01:29
Zymeworks Inc. unveils strategy focused on growing royalty portfolio and advancing novel medicines for difficult-to-treat diseases
Zymeworks Inc. Files Initial Beneficial Ownership Statement for Mark Hollywood, EVP & Chief Operating Officer
Reuters  ·  01-14
Zymeworks Inc. Files Initial Beneficial Ownership Statement for Mark Hollywood, EVP & Chief Operating Officer
Zymeworks Inc. Files Initial Statement of Beneficial Ownership for Director Brian N. Cherry
Reuters  ·  01-14
Zymeworks Inc. Files Initial Statement of Beneficial Ownership for Director Brian N. Cherry
BUZZ-U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners
Reuters  ·  01-12
BUZZ-U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners
Zymeworks Chief Finance, Medical, Scientific Officers Leaving in Executive Reorg
Dow Jones  ·  01-12
Zymeworks Chief Finance, Medical, Scientific Officers Leaving in Executive Reorg
Zymeworks Inc. unveils pipeline progress and partnership milestones in latest corporate presentation
Reuters  ·  01-12
Zymeworks Inc. unveils pipeline progress and partnership milestones in latest corporate presentation
Zymeworks Inc. Appoints New Executives and Board Member
Reuters  ·  01-12
Zymeworks Inc. Appoints New Executives and Board Member
Zymeworks Inc - Leone Patterson Will Depart From CFO Role During Q1 2026
THOMSON REUTERS  ·  01-12
Zymeworks Inc - Leone Patterson Will Depart From CFO Role During Q1 2026
Zymeworks Inc - Galbraith Assumes Role of Acting CFO
THOMSON REUTERS  ·  01-12
Zymeworks Inc - Galbraith Assumes Role of Acting CFO
Press Release: Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy
Dow Jones  ·  01-12
Press Release: Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy
Zymeworks outlines priorities, outlook for 2026
TIPRANKS  ·  01-12
Zymeworks outlines priorities, outlook for 2026
Zymeworks Inc. Outlines Strategy to Drive Long-Term Value Through Royalty Growth, Strategic Acquisitions, and Internal R&D Innovation Supported by Strengthened Financial Foundation
Reuters  ·  01-12
Zymeworks Inc. Outlines Strategy to Drive Long-Term Value Through Royalty Growth, Strategic Acquisitions, and Internal R&D Innovation Supported by Strengthened Financial Foundation
BRIEF-Zymeworks Outlines Strategic Priorities And Outlook For 2026
Reuters  ·  01-12
BRIEF-Zymeworks Outlines Strategic Priorities And Outlook For 2026
Zymeworks Outlines Strategic Priorities and Outlook for 2026
THOMSON REUTERS  ·  01-12
Zymeworks Outlines Strategic Priorities and Outlook for 2026
Zymeworks Inc: Global Phase 1 Clinical Trial Investigating ZW191 in Solid Tumors Is Ongoing With Dose Optimization of ZW191 in Ovarian Cancer
THOMSON REUTERS  ·  01-12
Zymeworks Inc: Global Phase 1 Clinical Trial Investigating ZW191 in Solid Tumors Is Ongoing With Dose Optimization of ZW191 in Ovarian Cancer
Zymeworks: up to $440 Mln in Milestone Payments Eligible to Be Earned Related to Regulatory Approvals of Ziihera in Gea in United States, Europe, Japan, & China
THOMSON REUTERS  ·  01-12
Zymeworks: up to $440 Mln in Milestone Payments Eligible to Be Earned Related to Regulatory Approvals of Ziihera in Gea in United States, Europe, Japan, & China
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Pacira Pharmaceuticals (PCRX) and Beta Bionics, Inc. (BBNX)
TIPRANKS  ·  01-09
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Pacira Pharmaceuticals (PCRX) and Beta Bionics, Inc. (BBNX)
Jazz Pharmaceuticals' Drug Extends Survival Past Two Years in Advanced Stomach Cancer Trial
Benzinga_recent_news  ·  01-08
Jazz Pharmaceuticals' Drug Extends Survival Past Two Years in Advanced Stomach Cancer Trial
Zymeworks Announces Positive Phase 3 Results for Ziihera in HER2-Positive Gastroesophageal Cancer
Reuters  ·  01-07
Zymeworks Announces Positive Phase 3 Results for Ziihera in HER2-Positive Gastroesophageal Cancer
Zymeworks Inc. Held Annual Shareholder Meeting
Reuters  ·  2025-12-31
Zymeworks Inc. Held Annual Shareholder Meeting

Introduction

Company Name.
ZYMEWORKS INC (US)
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--